Plain-English definitions of the terms used across the Kalibra Labs Research Library.
- 503A bulks list
- FDA list of bulk drug substances that licensed pharmacies may use to compound medicines under section 503A of the FD&C Act. See AOD-9604
- 503B bulks list
- FDA list of bulk drug substances that registered outsourcing facilities may use to compound drugs. See Semaglutide
- Accelerated approval
- An FDA pathway that approves a drug on a surrogate or intermediate endpoint, with a required confirmatory trial. See SS-31 (elamipretide)
- Acetylation
- Addition of an acetyl group to a molecule; TB-500 carries an acetyl cap on its first amino acid. See TB-500
- Acromegaly
- A condition caused by excess growth hormone in adults; a case linked to a GHRH-secreting tumor helped lead to GHRH's discovery. See Sermorelin
- ACTH(4–10)
- A seven-residue internal fragment of adrenocorticotropic hormone, studied separately from the full hormone. See Semax
- Actin
- A protein that forms filaments inside cells and is central to cell shape and movement. See TB-500
- Activin
- A TGF-beta family protein, first identified as a stimulator of FSH release, that follistatin binds and neutralizes. See Follistatin
- Acylation
- Attachment of a fatty-acid chain to a peptide, used in some GLP-1 analogues to promote binding to albumin. See Semaglutide
- AED
- Synthetic tripeptide alanine-glutamic acid-aspartic acid from the cartilage bioregulator patents. See Cartagen
- Alpha-MSH (alpha-melanocyte-stimulating hormone)
- A natural 13-amino-acid peptide hormone derived from proopiomelanocortin that acts on melanocortin receptors. See Melanotan I (afamelanotide)
- Alpha-MSH
- Alpha-melanocyte-stimulating hormone, a 13-amino-acid peptide hormone of the melanocortin family; KPV is its final three residues. See KPV
- Alternative splicing
- A process by which one gene yields more than one protein by joining its exons in different combinations. See Follistatin
- AMPK
- AMP-activated protein kinase, an enzyme complex that senses the cell's energy status through the balance of AMP and ATP. See AICAR
- Amylin analogue
- A modified, synthetic version of amylin designed to be more stable or longer-acting than the natural hormone. See Cagrilintide
- Amylin
- A 37-amino-acid peptide hormone co-secreted with insulin by pancreatic beta cells; also called islet amyloid polypeptide (IAPP). See Cagrilintide
- Angiotensin IV
- A six-amino-acid fragment (Val-Tyr-Ile-His-Pro-Phe) of the angiotensin peptide system, the parent of dihexa. See Dihexa
- Antimicrobial peptide
- A short peptide made by the body as part of innate immune defense against microorganisms. See LL-37
- Aviptadil
- The international nonproprietary name for synthetic vasoactive intestinal peptide. See VIP (vasoactive intestinal peptide)
- Bioregulator
- Khavinson's term for short peptides and peptide extracts derived from animal organs. See Thymalin
- Body Protection Compound (BPC)
- The name Croatian researchers gave to a roughly 40,000-dalton protein they isolated from gastric juice; BPC-157 is a short peptide based on it. See BPC-157
- c-Met
- The cell-surface receptor for hepatocyte growth factor (HGF). See Dihexa
- Cardiolipin
- A phospholipid found almost exclusively in the inner mitochondrial membrane. See SS-31 (elamipretide)
- Category 1 (FDA compounding)
- FDA’s group of nominated bulk drug substances that are under evaluation for the 503A bulks list; placement is not an approval. See VIP (vasoactive intestinal peptide)
- Category 2 (FDA compounding)
- FDA's list of bulk drug substances nominated for compounding that the agency considers to raise significant safety concerns. See BPC-157
- Cathelicidin
- A family of antimicrobial host-defense peptides; LL-37 is the only cathelicidin found in humans. See LL-37
- CD131 (beta common receptor)
- A receptor subunit shared by several cytokine receptors, proposed to pair with the EPO receptor in a tissue-protective receptor complex. See ARA-290 (cibinetide)
- CD36
- A scavenger receptor found on heart, blood vessel and other cells; reported as a second binding site for hexarelin. See Hexarelin
- Chimeric peptide
- A synthetic peptide built by joining sequences taken from two or more different proteins. See PNC-27
- Coenzyme
- A non-protein molecule that an enzyme needs in order to carry out its reaction. See NAD+
- COFEPRIS
- Mexico’s federal health regulator, which reviews and authorizes medicines. See Tesofensine
- Copper complex
- A compound in which a copper ion is bound to atoms of another molecule, such as a peptide, through coordinate bonds. See GHK-Cu
- Cyclic peptide
- A peptide whose chain is closed into a ring, often to improve stability or receptor binding. See Melanotan II
- Cytomedins
- Term used by Morozov and Khavinson for tissue-specific regulatory peptides first isolated from animal organ extracts. See Cardiogen
- D-amino acid
- The mirror-image form of an amino acid; rare in natural proteins and often used in synthetic peptides to resist enzymatic breakdown. See GHRP-6
- D-retro-inverso peptide
- A peptide made of D-amino acids in reversed sequence order, mimicking a natural peptide's side-chain layout while resisting protease breakdown. See FOXO4-DRI
- Decapeptide
- A peptide made of ten amino acids. See Gonadorelin
- Delta waves
- Slow, high-amplitude EEG oscillations (about 0.5–4 Hz) characteristic of deep non-REM sleep. See DSIP
- Disulfide bridge
- A covalent bond between the sulfur atoms of two cysteine residues that can fold a peptide chain into a ring. See Oxytocin
- Drug Affinity Complex (DAC)
- ConjuChem's reactive chemical linker designed to bond a peptide covalently to serum albumin at Cys34, extending its time in circulation. See CJC-1295
- Dual agonist
- A single molecule designed to activate two different receptors, such as the glucagon and GLP-1 receptors. See Survodutide
- E-peptide
- The C-terminal extension of the IGF-1 precursor; different E-peptides distinguish IGF-1 splice variants such as MGF. See MGF (Mechano Growth Factor) and PEG-MGF
- Emideltide
- The international nonproprietary name (INN) for delta sleep-inducing peptide. See DSIP
- Enzymatic hydrolysate
- A mixture produced by using enzymes to break proteins down into smaller peptides and amino acids. See Cerebrolysin
- Epithalamin
- A peptide extract of cattle pineal glands on which epitalon was modeled. See Epitalon
- Erythropoietic protoporphyria (EPP)
- A rare inherited metabolic disorder marked by phototoxic reactions to light. See Melanotan I (afamelanotide)
- Erythropoietin (EPO)
- A glycoprotein hormone, made mainly in the kidney, that regulates red blood cell production. See ARA-290 (cibinetide)
- One of three orphan nuclear receptors (ERRα, ERRβ, ERRγ) related in sequence to the estrogen receptor but not activated by estrogen. See SLU-PP-332
- Expression of concern
- A journal notice flagging possible problems with a published paper while an investigation is pending. See Dihexa
- GABA-A receptor
- A chloride-channel receptor for the neurotransmitter GABA; the site where benzodiazepine drugs bind. See Selank
- GHRH
- Growth hormone-releasing hormone, a 44-amino-acid hypothalamic peptide that signals the pituitary to release growth hormone; also called GRF. See Tesamorelin
- GIP (glucose-dependent insulinotropic polypeptide)
- An incretin hormone released from the upper small intestine; tirzepatide was designed to act at its receptor as well as the GLP-1 receptor. See Tirzepatide
- GLP-1 (glucagon-like peptide-1)
- A peptide hormone released from the intestine; it is the template for semaglutide, liraglutide and related analogues. See Semaglutide
- Glucagon receptor
- The receptor for glucagon, a pancreatic hormone; retatrutide was designed to act at it in addition to the GIP and GLP-1 receptors. See Retatrutide
- Glycoprotein
- A protein with sugar chains attached to some of its amino acids. See Follistatin
- Gonadotrope
- A cell type in the anterior pituitary that secretes luteinizing hormone and follicle-stimulating hormone. See Gonadorelin
- Gonadotropin-releasing hormone (GnRH)
- A hypothalamic decapeptide that signals the anterior pituitary to release LH and FSH; also called LH-RH. See Gonadorelin
- GRF(1-29)
- The first 29 amino acids of growth hormone-releasing factor (GHRH); the sequence of sermorelin and the backbone of several later analogs. See Sermorelin
- Growth hormone secretagogue receptor (GHS-R)
- The pituitary and hypothalamic receptor targeted by GHRPs; its natural ligand, ghrelin, was identified in 1999. See Ipamorelin
- Growth hormone-releasing peptide (GHRP)
- A family of synthetic peptides, beginning with GHRP-6 in 1984, designed to act at the growth hormone secretagogue receptor. See GHRP-2
- GSSG
- Oxidized glutathione: two glutathione molecules joined by a disulfide bond. See L-Glutathione
- hCAP18
- Human cationic antimicrobial protein of 18 kDa, the precursor from which LL-37 is cleaved. See LL-37
- HDM-2 (MDM2)
- A protein that binds and regulates the tumor-suppressor protein p53; HDM-2 is the name of the human form. See PNC-27
- Heptapeptide
- A peptide made of seven amino acids. See PT-141 (bremelanotide)
- Hexadecapeptide
- A peptide made of 16 amino acids. See AOD-9604
- Hexapeptide
- A peptide made of six amino acids. See GHRP-6
- Hexenoyl group
- A six-carbon unsaturated acyl group; in tesamorelin it is attached to the N-terminus of the GHRH sequence. See Tesamorelin
- Hypothalamic-pituitary-gonadal axis
- The hormonal signaling chain linking the hypothalamus, the pituitary gland and the gonads. See Kisspeptin-10
- IGF-binding proteins (IGFBPs)
- A family of proteins that bind IGF-1 in blood and tissue fluids and regulate how much reaches the IGF-1 receptor. See IGF-1 LR3
- INCI name
- International Nomenclature of Cosmetic Ingredients, the standardized label name for a cosmetic ingredient. See SNAP-8
- Incretin
- A gut hormone, such as GLP-1 or GIP, released after eating that acts on the pancreas. See Tirzepatide
- KISS1R (GPR54)
- The G protein-coupled receptor that binds kisspeptins; expressed on GnRH neurons in the hypothalamus. See Kisspeptin-10
- Lactam bridge
- A ring-closing amide bond formed between two amino-acid side chains within a peptide. See Melanotan II
- Lipidation
- Attaching a fatty-acid chain to a peptide, often to extend how long it persists in circulation. See Cagrilintide
- Melanocortin 1 receptor (MC1R)
- A melanocortin receptor subtype found on pigment-producing cells and other tissues. See Melanotan I (afamelanotide)
- Melanocortin receptors
- A family of five receptors (MC1R to MC5R) that respond to alpha-MSH and related peptides. See PT-141 (bremelanotide)
- Metastin
- Original name for kisspeptin-54, the longest peptide made from the KISS1 gene. See Kisspeptin-10
- Mitochondrial-derived peptide
- A small peptide encoded by a short open reading frame in mitochondrial DNA rather than in the cell nucleus. See MOTS-c
- Modified GRF (1-29)
- The four-substitution GHRH(1-29) analog without an albumin-binding linker; commonly sold as CJC-1295 no DAC. See CJC-1295
- Monoamine reuptake inhibitor
- A compound designed to block the transporters that clear neurotransmitters such as dopamine, noradrenaline and serotonin from the synapse. See Tesofensine
- NADH
- The reduced form of NAD+, carrying two electrons and a proton. See NAD+
- National Priority Voucher (CNPV)
- An FDA pilot program launched in 2025 that gives selected applications an accelerated review timeline. See Orforglipron
- Nicotinamide riboside (NR)
- A vitamin B3 form that cells can convert into NAD+. See NAD+
- NMPA
- China’s National Medical Products Administration, the country’s drug regulator. See Mazdutide
- NNMT
- Nicotinamide N-methyltransferase, an enzyme that transfers a methyl group from S-adenosylmethionine to nicotinamide, forming 1-methylnicotinamide. See 5-Amino-1MQ
- Nonapeptide
- A peptide made of nine amino acids. See DSIP
- Nucleoside
- A molecule made of a nitrogen-containing base joined to a five-carbon sugar such as ribose; adding phosphate gives a nucleotide. See AICAR
- Oxyntomodulin
- A naturally occurring gut peptide that interacts with both the glucagon receptor and the GLP-1 receptor. See Mazdutide
- p53
- A tumor-suppressor protein that can halt the cell cycle or trigger apoptosis. See FOXO4-DRI
- Palmitic acid
- A 16-carbon saturated fatty acid; in liraglutide it is attached to lysine 26 through a glutamic acid spacer. See Liraglutide
- Pan-agonist
- A compound designed to activate every member of a receptor family rather than a single subtype. See SLU-PP-332
- Partial agonist
- A compound that activates a receptor but produces less than the maximal response of a full agonist in a given assay. See Orforglipron
- PCAC
- FDA's Pharmacy Compounding Advisory Committee, which advises on which bulk substances may be used in compounding. See Thymosin Alpha-1
- PEGylation
- Attachment of polyethylene glycol (PEG) chains to a peptide or protein, typically to slow its clearance. See MGF (Mechano Growth Factor) and PEG-MGF
- Penetratin
- A 16-residue cell-penetrating sequence from the third helix of the Drosophila Antennapedia homeodomain, used to carry attached cargo across cell membranes. See PNC-27
- Pentadecapeptide
- A peptide made of 15 amino acids. See BPC-157
- Pentapeptide
- A peptide made of five amino acids. See Ipamorelin
- PepT1
- A peptide transporter in intestinal cells that moves small peptides into the cell. See KPV
- Peptide bioregulator
- Term used by Khavinson's school for short peptides proposed to regulate specific tissues. See Cartagen
- Phage display
- A screening method that uses bacteriophages carrying large libraries of peptides to find sequences that bind a chosen target. See Adipotide
- Pharmacy Compounding Advisory Committee (PCAC)
- An FDA advisory panel that recommends which bulk substances pharmacies may use in compounding. See Melanotan II
- Phenyltropane
- A class of synthetic molecules built on a tropane ring with an attached phenyl group. See Tesofensine
- Porcine
- Derived from pigs. See Cerebrolysin
- Posterior pituitary
- The rear lobe of the pituitary gland, which releases the hormones oxytocin and vasopressin. See Oxytocin
- Pralmorelin
- The nonproprietary drug name for GHRP-2; approved in Japan as a diagnostic agent. See GHRP-2
- Pro-apoptotic peptide
- A peptide sequence designed to trigger apoptosis, the cell's programmed self-destruction process. See Adipotide
- Pro-Gly-Pro
- A proline-glycine-proline tripeptide added to Semax and Selank to slow enzymatic breakdown. See Semax
- Prohibitin
- A protein that, in M.D. Anderson studies, was identified on the surface of blood vessels supplying white adipose tissue. See Adipotide
- Pyroglutamate (pGlu)
- A cyclized form of glutamine or glutamic acid often found at the N-terminus of peptides. See ARA-290 (cibinetide)
- Quinolinium
- A positively charged ring system derived from quinoline by adding a substituent, such as a methyl group, to its nitrogen atom. See 5-Amino-1MQ
- Senescent cell
- A cell that has permanently stopped dividing but remains alive and metabolically active. See FOXO4-DRI
- Sequence homology
- The share of positions at which two peptide or protein sequences carry the same amino acid. See Liraglutide
- Small molecule
- A low-molecular-weight organic compound, as opposed to a peptide or protein built from chains of amino acids. See Orforglipron
- SNARE complex
- A protein assembly at nerve endings that lets vesicles fuse with the cell membrane and release neurotransmitter. See SNAP-8
- Somatomedin
- Name proposed in 1972 for the growth hormone-dependent serum factor now known as IGF-1. See IGF-1 LR3
- Sortilin
- A neuronal sorting receptor protein whose propeptide is cleaved to release spadin. See PE-22-28
- Spadin
- A 17-amino-acid peptide released from the sortilin propeptide, reported to inhibit TREK-1. See PE-22-28
- Splice variant
- One of several proteins made from the same gene when its coding segments are joined in different combinations. See MGF (Mechano Growth Factor) and PEG-MGF
- Szeto-Schiller peptides
- A family of small synthetic peptides, including SS-31, named after designers Hazel Szeto and Peter Schiller. See SS-31 (elamipretide)
- Telomerase
- An enzyme that adds repeat sequences to the ends of chromosomes (telomeres). See Epitalon
- Tetrapeptide
- A peptide made of four amino acids joined by peptide bonds. See Cardiogen
- Thiol
- A sulfur-hydrogen (-SH) chemical group, found in cysteine. See L-Glutathione
- Thymalfasin
- The drug name for synthetic thymosin alpha-1. See Thymosin Alpha-1
- Thymosin beta-4
- A natural 43-amino-acid protein first isolated from calf thymus that binds actin; TB-500 is a synthetic fragment of it. See TB-500
- Thymosin fraction 5
- A partially purified calf-thymus extract containing more than 30 peptides, the source of thymosin alpha-1. See Thymosin Alpha-1
- Thymus
- A gland in the chest where immune T cells mature. See Thymalin
- TREK-1
- A two-pore-domain potassium channel (gene KCNK2) that helps regulate neuronal excitability. See PE-22-28
- Tripeptide
- A peptide made of three amino acids joined by peptide bonds. See GHK-Cu
- Triple agonist
- A single molecule designed to activate three different receptors; for retatrutide, the GIP, GLP-1 and glucagon receptors. See Retatrutide
- Tuftsin
- A natural four-amino-acid peptide (Thr-Lys-Pro-Arg) cleaved from immunoglobulin G, discovered in 1970. See Selank
- VPAC receptors
- VPAC1 and VPAC2, two G protein-coupled receptors that bind both VIP and PACAP. See VIP (vasoactive intestinal peptide)
For Research Use Only. Kalibra Labs supplies this compound as a lyophilized research material for in-vitro laboratory use. It is not for human or veterinary use and not for use in diagnostic or therapeutic procedures. This page is a scientific and historical reference; it is not medical advice and makes no claim about use in people or animals.
Frequently asked questions
What does the peptide research glossary include?
Plain-English definitions of the scientific and regulatory terms used across the Kalibra Labs Research Library, including peptide structures, analytical methods and FDA compounding categories. Each term links to a page where it is used.
